Q1

Lilly to Acquire Centessa Pharmaceuticals to Advance Treatments for Sleep-Wake Disorders

Eli Lilly and Company (NYSE: LLY) and Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage company developing a new class of medicines for the treatment of excessive daytime sleepiness and other neurological conditions, announces a definitive agreement for Lilly to acquire Centessa. Centessa is advancing a pipeline of orexin receptor 2 (OX2R) agonists designed to address […]

Lilly to Acquire Centessa Pharmaceuticals to Advance Treatments for Sleep-Wake Disorders Read More »

KKR and Taiyo Holdings Agree to Privatization to Accelerate Long-Term Growth

KKR, a leading global investment firm, and Taiyo Holdings Co., Ltd. (“Taiyo Holdings” or the “Company”; TSE stock code 4626), announce that KJ005 Co., Ltd. (the “Offeror”), an entity owned by investment funds managed by KKR, intends to make a tender offer to acquire all the common shares of Taiyo Holdings (the “Tender Offer”). Taiyo

KKR and Taiyo Holdings Agree to Privatization to Accelerate Long-Term Growth Read More »

Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology

Biogen Inc. (Nasdaq: BIIB) and Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announce the companies have entered into a definitive agreement under which Biogen has agreed to acquire all outstanding shares of Apellis for $41.00 per share in cash at closing, or approximately $5.6 billion. Apellis stockholders will also receive a nontransferable CVR for each Apellis share

Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology Read More »

Samsung Biologics Completes Acquisition of GSK’s Manufacturing Facility in Rockville, Maryland

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announces the completion of its acquisition of a manufacturing facility in Rockville, Maryland from GSK, establishing the company’s first manufacturing presence in the United States. The Rockville site comprises two cGMP manufacturing plants with a combined 60,000-liter drug substance capacity, supporting both clinical

Samsung Biologics Completes Acquisition of GSK’s Manufacturing Facility in Rockville, Maryland Read More »

Radon Medical Imaging Announces Acquisition of Majestic Medical Solutions

Radon Medical Imaging (Radon), a leading medical imaging equipment maintenance and repair services company, announces it has acquired Majestic Medical Solutions (Majestic), a trusted provider of medical imaging equipment services and solutions based in Baton Rouge, Louisiana. The transaction closed in the fourth quarter of 2025 and marks Radon’s fourth add-on acquisition, reinforcing its position

Radon Medical Imaging Announces Acquisition of Majestic Medical Solutions Read More »

SALT Dental Partners Strengthens Greater Seattle Market with Haeger Orthodontics

SALT Dental Partners is pleased to announce its partnership with Haeger Orthodontics, a two-doctor orthodontic group serving the Greater Seattle market across two locations. This partnership adds further density in one of SALT’s most established regions, alongside Cascadia Kids Dentistry, Kirby Nelson Orthodontics, Pristera Orthodontics, Seattle Kids Dentistry, and Cascadia Smiles Orthodontics. Haeger Orthodontics represents

SALT Dental Partners Strengthens Greater Seattle Market with Haeger Orthodontics Read More »

Scroll to Top